{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:16:37Z","timestamp":1791303397636,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41591-021-01389-4","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T16:06:53Z","timestamp":1623946013000},"page":"1458-1470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Retrieval of vector integration sites from cell-free DNA"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6366-4224","authenticated-orcid":false,"given":"Daniela","family":"Cesana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-3384","authenticated-orcid":false,"given":"Andrea","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rudilosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangela","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4220-2474","authenticated-orcid":false,"given":"Giulio","family":"Spinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Schiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Acquati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-4087","authenticated-orcid":false,"given":"Francesca","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Calbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Witzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-4056","authenticated-orcid":false,"given":"Frederic D.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-997X","authenticated-orcid":false,"given":"Alessio","family":"Cantore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9507-9003","authenticated-orcid":false,"given":"Pietro","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7806-0968","authenticated-orcid":false,"given":"Emmanuelle","family":"Six","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-1717","authenticated-orcid":false,"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-527X","authenticated-orcid":false,"given":"Luigi","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-6067","authenticated-orcid":false,"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature15818","volume":"526","author":"L Naldini","year":"2015","unstructured":"Naldini, L. Gene therapy returns to centre stage. Nature 526, 351\u2013360 (2015).","journal-title":"Nature"},{"key":"1389_CR2","doi-asserted-by":"crossref","unstructured":"Dunbar, C. E. et al. Gene therapy comes of age. Science 359, eaan4672 (2018).","DOI":"10.1126\/science.aan4672"},{"key":"1389_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415\u2013419 (2003).","journal-title":"Science"},{"key":"1389_CR4","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1172\/JCI35798","volume":"118","author":"SJ Howe","year":"2008","unstructured":"Howe, S. J. et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143\u20133150 (2008).","journal-title":"J. Clin. Invest."},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nm1393","volume":"12","author":"MG Ott","year":"2006","unstructured":"Ott, M. G. et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401\u2013409 (2006).","journal-title":"Nat. Med."},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nm.2088","volume":"16","author":"S Stein","year":"2010","unstructured":"Stein, S. et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat. Med. 16, 198\u2013204 (2010).","journal-title":"Nat. Med."},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"227ra233","DOI":"10.1126\/scitranslmed.3007280","volume":"6","author":"CJ Braun","year":"2014","unstructured":"Braun, C. J. et al. Gene therapy for Wiskott\u2013Aldrich syndrome\u2014long-term efficacy and genotoxicity. Sci. Transl. Med. 6, 227ra233 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1389_CR8","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI35700","volume":"118","author":"S Hacein-Bey-Abina","year":"2008","unstructured":"Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132\u20133142 (2008).","journal-title":"J. Clin. Invest."},{"key":"1389_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo, M. et al. Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia. Nature 467, 318\u2013322 (2010).","journal-title":"Nature"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307\u2013312 (2018).","journal-title":"Nature"},{"key":"1389_CR11","unstructured":"Cesana, D. et al. Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. J. Clin. Invest. 122, 1667\u20131676 (2012)."},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1172\/JCI37630","volume":"119","author":"E Montini","year":"2009","unstructured":"Montini, E. et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 119, 964\u2013975 (2009).","journal-title":"J. Clin. Invest."},{"key":"1389_CR13","unstructured":"Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott\u2013Aldrich syndrome. Science 341, 1233151 (2013)."},{"key":"1389_CR14","doi-asserted-by":"crossref","unstructured":"Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 1233158 (2013).","DOI":"10.1126\/science.1233158"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","volume":"25","author":"S Marktel","year":"2019","unstructured":"Marktel, S. et al. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ss-thalassemia. Nat. Med. 25, 234\u2013241 (2019).","journal-title":"Nat. Med."},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","volume":"388","author":"M Sessa","year":"2016","unstructured":"Sessa, M. et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet 388, 476\u2013487 (2016).","journal-title":"Lancet"},{"key":"1389_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","volume":"10","author":"E Crowley","year":"2013","unstructured":"Crowley, E., Di Nicolantonio, F., Loupakis, F. & Bardelli, A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10, 472\u2013484 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1389_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan, J. C. M. et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer 17, 223\u2013238 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1389_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/gm568","volume":"6","author":"S Firouzi","year":"2014","unstructured":"Firouzi, S. et al. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 6, 46 (2014).","journal-title":"Genome Med."},{"key":"1389_CR20","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet, N. A. et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117, 3113\u20133122 (2011).","journal-title":"Blood"},{"key":"1389_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/bioinformatics\/bts004","volume":"28","author":"CC Berry","year":"2012","unstructured":"Berry, C. C. et al. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics 28, 755\u2013762 (2012).","journal-title":"Bioinformatics"},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12859-017-1937-9","volume":"18","author":"G Spinozzi","year":"2017","unstructured":"Spinozzi, G. et al. VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites. BMC Bioinformatics 18, 520 (2017).","journal-title":"BMC Bioinformatics"},{"key":"1389_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-06924-0","volume":"21","author":"DW Wells","year":"2020","unstructured":"Wells, D. W. et al. Correction to: An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses. BMC Genomics 21, 517 (2020).","journal-title":"BMC Genomics"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","volume":"117","author":"A Biffi","year":"2011","unstructured":"Biffi, A. et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117, 5332\u20135339 (2011).","journal-title":"Blood"},{"key":"1389_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","volume":"110","author":"AR Schroder","year":"2002","unstructured":"Schroder, A. R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521\u2013529 (2002).","journal-title":"Cell"},{"key":"1389_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrmicro.2016.162","volume":"15","author":"M Lusic","year":"2017","unstructured":"Lusic, M. & Siliciano, R. F. Nuclear landscape of HIV-1 infection and integration. Nat. Rev. Microbiol. 15, 69\u201382 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193\u20131203 (2016).","journal-title":"Nat. Genet."},{"key":"1389_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.omtm.2020.03.021","volume":"17","author":"JE Adair","year":"2020","unstructured":"Adair, J. E. et al. DNA barcoding in nonhuman primates reveals important limitations in retrovirus integration site analysis. Mol. Ther. Methods Clin. Dev. 17, 796\u2013809 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","volume":"18","author":"M Cavazzana","year":"2019","unstructured":"Cavazzana, M., Bushman, F. D., Miccio, A., Andre-Schmutz, I. & Six, E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat. Rev. Drug Discov. 18, 447\u2013462 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1389_CR30","first-page":"1","volume":"25","author":"Abstract_753.","year":"2017","unstructured":"Abstract_753. ASGCT Annual Meeting Abstracts. Mol. Ther. 25, 1\u2013363 (2017).","journal-title":"Mol. Ther."},{"key":"1389_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/hum.2015.047","volume":"26","author":"MP Cicalese","year":"2015","unstructured":"Cicalese, M. P. & Aiuti, A. Clinical applications of gene therapy for primary immunodeficiencies. Hum. Gene Ther. 26, 210\u2013219 (2015).","journal-title":"Hum. Gene Ther."},{"key":"1389_CR32","unstructured":"Schiroli, G. et al. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Sci. Transl. Med. 9, eaan0820 (2017)."},{"key":"1389_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/ismej.2013.10","volume":"7","author":"B Haegeman","year":"2013","unstructured":"Haegeman, B. et al. Robust estimation of microbial diversity in theory and in practice. ISME J. 7, 1092\u20131101 (2013).","journal-title":"ISME J."},{"key":"1389_CR34","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1182\/blood-2009-12-257352","volume":"115","author":"GP Wang","year":"2010","unstructured":"Wang, G. P. et al. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. Blood 115, 4356\u20134366 (2010).","journal-title":"Blood"},{"key":"1389_CR35","doi-asserted-by":"publisher","first-page":"277ra228","DOI":"10.1126\/scitranslmed.aaa1405","volume":"7","author":"A Cantore","year":"2015","unstructured":"Cantore, A. et al. Liver-directed lentiviral gene therapy in a dog model of hemophilia B. Sci. Transl. Med. 7, 277ra228 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.ymthe.2017.03.033","volume":"25","author":"AW Nienhuis","year":"2017","unstructured":"Nienhuis, A. W., Nathwani, A. C. & Davidoff, A. M. Gene therapy for hemophilia. Mol. Ther. 25, 1163\u20131167 (2017).","journal-title":"Mol. Ther."},{"key":"1389_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2307\/2531532","volume":"43","author":"A Chao","year":"1987","unstructured":"Chao, A. Estimating the population size for capture-recapture data with unequal catchability. Biometrics 43, 783\u2013791 (1987).","journal-title":"Biometrics"},{"key":"1389_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1196\/annals.1448.002","volume":"1137","author":"AN Butt","year":"2008","unstructured":"Butt, A. N. & Swaminathan, R. Overview of circulating nucleic acids in plasma\/serum. Ann. NY Acad. Sci. 1137, 236\u2013242 (2008).","journal-title":"Ann. NY Acad. Sci."},{"key":"1389_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","volume":"1793","author":"A Ballabio","year":"2009","unstructured":"Ballabio, A. & Gieselmann, V. Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta 1793, 684\u2013696 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"1389_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71357-4","volume":"10","author":"M Peled","year":"2020","unstructured":"Peled, M. et al. Cell-free DNA concentration in patients with clinical or mammographic suspicion of breast cancer. Sci. Rep. 10, 14601 (2020).","journal-title":"Sci. Rep."},{"key":"1389_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach, H., Hoon, D. S. & Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426\u2013437 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"1389_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6562-8","volume":"20","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma. BMC Cancer 20, 102 (2020).","journal-title":"BMC Cancer"},{"key":"1389_CR43","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1183\/13993003.00676-2015","volume":"46","author":"C Tissot","year":"2015","unstructured":"Tissot, C. et al. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer. Eur. Respir. J. 46, 1773\u20131780 (2015).","journal-title":"Eur. Respir. J."},{"key":"1389_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07466-6","volume":"9","author":"J Moss","year":"2018","unstructured":"Moss, J. et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun. 9, 5068 (2018).","journal-title":"Nat. Commun."},{"key":"1389_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/03014460.2013.807878","volume":"40","author":"E Bianconi","year":"2013","unstructured":"Bianconi, E. et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 40, 463\u2013471 (2013).","journal-title":"Ann. Hum. Biol."},{"key":"1389_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-physiol-021113-170255","volume":"77","author":"BZ Stanger","year":"2015","unstructured":"Stanger, B. Z. Cellular homeostasis and repair in the mammalian liver. Annu Rev. Physiol. 77, 179\u2013200 (2015).","journal-title":"Annu Rev. Physiol."},{"key":"1389_CR47","unstructured":"Milani, M. et al. Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Sci. Transl. Med. 11, eaav7325 (2019)."},{"key":"1389_CR48","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1053\/j.gastro.2009.05.044","volume":"137","author":"AW Duncan","year":"2009","unstructured":"Duncan, A. W., Dorrell, C. & Grompe, M. Stem cells and liver regeneration. Gastroenterology 137, 466\u2013481 (2009).","journal-title":"Gastroenterology"},{"key":"1389_CR49","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","volume":"43","author":"V Racanelli","year":"2006","unstructured":"Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43, S54\u2013S62 (2006).","journal-title":"Hepatology"},{"key":"1389_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/hep.20746","volume":"42","author":"D Benten","year":"2005","unstructured":"Benten, D. et al. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. Hepatology 42, 140\u2013148 (2005).","journal-title":"Hepatology"},{"key":"1389_CR51","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.20969","volume":"43","author":"N Fausto","year":"2006","unstructured":"Fausto, N., Campbell, J. S. & Riehle, K. J. Liver regeneration. Hepatology 43, S45\u2013S53 (2006).","journal-title":"Hepatology"},{"key":"1389_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ncb3309","volume":"18","author":"JL Kopp","year":"2016","unstructured":"Kopp, J. L., Grompe, M. & Sander, M. Stem cells versus plasticity in liver and pancreas regeneration. Nat. Cell Biol. 18, 238\u2013245 (2016).","journal-title":"Nat. Cell Biol."},{"key":"1389_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1056\/NEJMoa1000164","volume":"363","author":"S Hacein-Bey-Abina","year":"2010","unstructured":"Hacein-Bey-Abina, S. et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 363, 355\u2013364 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1389_CR54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1373\/clinchem.2018.298323","volume":"65","author":"R Meddeb","year":"2019","unstructured":"Meddeb, R., Pisareva, E. & Thierry, A. R. Guidelines for the preanalytical conditions for analyzing circulating cell-free DNA. Clin. Chem. 65, 623\u2013633 (2019).","journal-title":"Clin. Chem."},{"key":"1389_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6647-4","volume":"21","author":"DW Wells","year":"2020","unstructured":"Wells, D. W. et al. An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses. BMC Genomics 21, 216 (2020).","journal-title":"BMC Genomics"},{"key":"1389_CR56","first-page":"28","volume":"2","author":"TL Bailey","year":"1994","unstructured":"Bailey, T. L. & Elkan, C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28\u201336 (1994).","journal-title":"Proc. Int. Conf. Intell. Syst. Mol. Biol."},{"key":"1389_CR57","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/bioinformatics\/btr064","volume":"27","author":"CE Grant","year":"2011","unstructured":"Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017\u20131018 (2011).","journal-title":"Bioinformatics"},{"key":"1389_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-5063-5","volume":"19","author":"AT Simonsen","year":"2018","unstructured":"Simonsen, A. T. et al. Systematic evaluation of signal-to-noise ratio in variant detection from single cell genome multiple displacement amplification and exome sequencing. BMC Genomics 19, 681 (2018).","journal-title":"BMC Genomics"},{"key":"1389_CR59","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1002\/sim.996","volume":"20","author":"A Chao","year":"2001","unstructured":"Chao, A., Tsay, P. K., Lin, S. H., Shau, W. Y. & Chao, D. Y. The applications of capture\u2013recapture models to epidemiological data. Stat. Med. 20, 3123\u20133157 (2001).","journal-title":"Stat. Med."},{"key":"1389_CR60","first-page":"348","volume":"45","author":"ZE Schnabel","year":"1938","unstructured":"Schnabel, Z. E. The estimation of the total fish population of a lake. Am. Math. Monthly 45, 348\u2013352 (1938).","journal-title":"Am. Math. Monthly"},{"key":"1389_CR61","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet, N. A. et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117, 3113\u20133122 (2011).","journal-title":"Blood"},{"key":"1389_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.stem.2016.04.016","volume":"19","author":"L Biasco","year":"2016","unstructured":"Biasco, L. et al. In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases. Cell Stem Cell 19, 107\u2013119 (2016).","journal-title":"Cell Stem Cell"},{"key":"1389_CR63","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41591-018-0195-3","volume":"24","author":"S Scala","year":"2018","unstructured":"Scala, S. et al. Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans. Nat. Med. 24, 1683\u20131690 (2018).","journal-title":"Nat. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01389-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T14:21:38Z","timestamp":1672496498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1038\/s41591-021-01389-4","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.C. and E.M. are inventors of the LiBIS-seq method for which a United Kingdom patent was filed in April 2019. The patent is owned and managed by the San Raffaele Scientific Institute and the Telethon Foundation. All other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}